Avapritinib in CBF-AML With KIT Mutations

Clinical trial NCT05821738 · UNKNOWN

Trial details

NCT number: NCT05821738
Sponsor: The First Affiliated Hospital of Soochow University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Core Binding Factor Acute Myeloid Leukemia KIT Mutation-Related Tumors

Start date: 2022-06-01
Primary completion: 2024-12-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.